Safety and Efficacy of Low-Dose Prednisolone with Pirfenidone in Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Matsubayashi, S. [1 ]
Izumi, S. [1 ]
Takumida, H. [1 ]
Watanabe, H. [1 ]
Matsumoto, S. [1 ]
Kusaba, Y. [1 ]
Katsuno, T. [1 ]
Kakuwa, T. [1 ]
Tsujimoto, Y. [1 ]
Sakamoto, K. [1 ]
Hashimoto, M. [1 ]
Ishii, S. [1 ]
Morino, E. [1 ]
Suzuki, M. [1 ]
Takasaki, J. [1 ]
Naka, G. [1 ]
Iikura, M. [1 ]
Takeda, Y. [1 ]
Sugiyama, H. [1 ]
机构：
[1] Natl Ctr Global Hlth & Med, Resp Med, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4769
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital
    Myung Jin Song
    Sung Woo Moon
    Ji Soo Choi
    Sang Hoon Lee
    Su Hwan Lee
    Kyung Soo Chung
    Ji Ye Jung
    Young Ae Kang
    Moo Suk Park
    Young Sam Kim
    Joon Chang
    Song Yee Kim
    Scientific Reports, 10
  • [22] Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
    Li, Hui
    Yang, Jing
    Chen, Shanshan
    Wang, Peile
    Yu, Xueqing
    Zhou, Qingwei
    Zhang, Xiaojian
    Zhang, Guojun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] Safety and Efficacy of Early and Long-Term Use of Pirfenidone in Idiopathic Pulmonary Fibrosis
    Tzilas, Vasilios
    Tzouvelekis, Argyrios
    Bouros, Demosthenes
    RESPIRATION, 2019, 98 (01) : 16 - 18
  • [24] The Efficacy and Safety of Herbal Medicine with Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review
    Cho, Suyeon
    Park, Sunju
    Lee, Ju Ah
    Jung, Hee-Jae
    Kim, Kwan-Il
    Lee, Beom-Joon
    PROCESSES, 2022, 10 (12)
  • [25] The Efficacy and Safety Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis
    Ogawa, Kazumasa
    Miyamoto, Atsushi
    Hanada, Shigeo
    Takahashi, Yui
    Murase, Kyoko
    Mochizuki, Sayaka
    Uruga, Hironori
    Takaya, Hisashi
    Morokawa, Nasa
    Kishi, Kazuma
    INTERNAL MEDICINE, 2018, 57 (19) : 2813 - 2818
  • [26] Safety, Tolerability and Efficacy of Nintedanib Switched from Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Ikeda, S.
    Sekine, A.
    Baba, T.
    Katano, T.
    Matama, G.
    Aiko, N.
    Isomoto, K.
    Otoshi, R.
    Tabata, E.
    Shintani, R.
    Sadoyama, S.
    Yamakawa, H.
    Niwa, T.
    Nakagawa, H.
    Oda, T.
    Okuda, R.
    Kitamura, H.
    Komatsu, S.
    Hagiwara, E.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] LOW-DOSE CORTICOSTEROID-THERAPY FOR IDIOPATHIC PULMONARY FIBROSIS
    KRINSKY, G
    RADIOLOGY, 1994, 192 (02) : 582 - 582
  • [28] Pirfenidone in idiopathic pulmonary fibrosis
    Swigris, J.
    Fairclough, D.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 695 - 696
  • [29] PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Maher, T. M.
    DRUGS OF TODAY, 2010, 46 (07) : 473 - 482
  • [30] Pirfenidone In Idiopathic Pulmonary Fibrosis
    Carter, Natalie J.
    DRUGS, 2011, 71 (13) : 1721 - 1732
12345